EMEA-002054-PIP02-18

Table of contents

Key facts

Active substance
Odevixibat
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0368/2020
PIP number
EMEA-002054-PIP02-18
Pharmaceutical form(s)
  • Age-appropriate oral liquid dosage form
  • Capsule, hard
Condition(s) / indication(s)
Treatment of biliary atresia
Route(s) of administration
Oral use
Contact for public enquiries
Albireo AB

Tel. +46 31741 14 80
E-mail: info@albireopharma.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating